Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 646...

FDA Drug Recall #D-1541-2014 — Class II — July 24, 2014

Recall Summary

Recall Number D-1541-2014
Classification Class II — Moderate risk
Date Initiated July 24, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Wockhardt Usa Inc.
Location Parsippany, NJ
Product Type Drugs
Quantity 11,661 HDPE bottles

Product Description

Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA

Reason for Recall

Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.

Distribution Pattern

Nationwide

Lot / Code Information

Lot # a) LN11005, Exp 04/15; LN11006; Exp 04/15; b) LN10979; Exp. 04/15, LN10980; Exp. 04/15

Other Recalls from Wockhardt Usa Inc.

Recall # Classification Product Date
D-0051-2018 Class III Enalapril Maleate tablets, USP, 5mg, 1000-count... Aug 22, 2017
D-1346-2015 Class II Lisinopril Tablets USP, 5 mg, 1000-count bottle... Jul 29, 2015
D-1347-2015 Class II Lisinopril Tablets USP, 20 mg, 1000-count bottl... Jul 29, 2015
D-1265-2015 Class II Famotodine Tablets, USP, 20 mg Tablets, Packag... Apr 22, 2015
D-1250-2015 Class II Famotodine Tablets, USP, 40 mg Tablets, Packag... Apr 22, 2015

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.